Specifically, the MHRA approved Zynyz as a first- and second-line treatment for adults with advanced squamous cell carcinoma ...

Earlier this year I was sent a certificate showing 99.6% purity. It had a lab name, a test date, and a clean chromatogram. It ...

The approval gives Lilly first-mover advantage in China – the world's second-largest pharma market – and an edge over Novo, ...

Private equity firm Blackstone Life Sciences has agreed to provide up to $1.5 billion in funding to Pfizer for the ...

Reports are emerging that the Commissioner's National Priority Voucher (CNPV) scheme launched by former FDA Commissioner ...

Ahead of World Diabetes Day on Saturday, Novo has said it will provide $200 million over the next 10 years to support World ...

One of the antibody-drug conjugates at the heart of Pfizer's $43 billion acquisition of Seagen three years ago has failed a keenly anticipated phase 3 trial in lung cancer. The results of the ...

The Moderna Innovation and Technology Centre (MITC) at Harwell Science and Innovation Campus. Moderna and the University of Oxford in the UK have been cleared to start human trials of what could be ...

Pfizer and Arvinas are poised to bring the third oral selective oestrogen receptor degrader (SERD) to market in the US, after the FDA cleared vepdegestrant for a form of breast cancer. Vepdegestrant ...

UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...

Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...

The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...